Rhinitis, Vasomotor: Clinical Trials

12 trials for Rhinitis, Vasomotor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 2 recruiting. 6 Not applicable, 5 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable6Completed 4, Recruiting 2
Phase 35Completed 5
Phase 41Completed 1

Follow Rhinitis, Vasomotor: new trials by email Literature Review of Rhinitis, Vasomotor trials Research Report on Rhinitis, Vasomotor

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of Lavender Aromatherapy on Anxiety and Pain Reduction During Awake Otolaryngologic Procedures
Lavender Aromatherapy, Placebo Aromatherapy - Inferior Turbinate Hypertrophy, Chronic Rhinosinusitis (CRS)
Not applicableRecruitingCedars-Sinai Medical Center1842025-12-012025-12-23
Evaluation of Bactorinol® Nasal Spray in Adult Patients With Vasomotor Rhinitis
Bactorinol® Nasal Spray, Isotonic Saline Solution - Vasomotor Rhinitis
Not applicableCompletedLiaquat University of Medical & Health Sciences1202025-12-012026-04-23
Comparison of the Effects for Lightening the Shiners Among Different Treatments for Rhinitis
Oral Levocetirizine, Combined Intranasal Mometasone Furoate with oral Levocetirizine, Combined Intranasal Mometasone Furoate with oral Levocetirizine plus intranasal Oxymetazoline - Allergic Rhinitis, Vasomotor Rhinitis
Not applicableRecruitingCamillians Saint Mary's Hospital Luodong4502020-06-162022-04-27
Nasal Saline Irrigation After Radiation Therapy for Oropharyngeal Cancer
Saline mixture - Nasal Obstruction, Rhinitis, Vasomotor
Not applicableCompletedLisa Shnayder362013-01-012015-11-04
Efficacy/Safety of Pseudoephedrine Plus Levocetirizine Versus Placebo in Patients With Vasomotor Rhinitis
Pseudoephedrine / Levocetirizine - Vasomotor Rhinitis
Phase 3CompletedHanmi Pharmaceutical Company Limited1372011-05-012013-05-23
Safety and Efficacy of Olopatadine 0.6% and Azelastine 137 Mcg in Vasomotor Rhinitis
Olopatadine HCL (Patanase) Nasal Spray, 0.6%, Azelastine HCl (Astelin) Nasal Spray, 137 mcg - Vasomotor Rhinitis
Phase 4CompletedAlcon Research1292009-09-012011-05-10
Consumer Preference Study of Two Formulations of Phenylephrine Hydrochloride (Study CL2008-15)(P07530)(COMPLETED)
Phenylephrine Hydrochloride (HCl) Extended Release (ER) Tablets 30 mg, Phenylephrine Hydrochloride (HCl) Immediate Release (IR) tablets, 10 mg - Vasomotor Rhinitis, Seasonal Allergic Rhinitis
Phase 3CompletedBayer3312009-08-012015-03-11
Nasal Physiologic Reactivity of Nonallergic Rhinitics to Cold Air Provocation
Cold-dry air provocation, Warm-moist air provocation - Vasomotor Rhinitis
Not applicableCompletedAssociated Scientists to Help Minimize Allergies242006-12-012017-03-06
Study Of Adults And Adolescents With Vasomotor Rhinitis
GW685698X - Rhinitis, Vasomotor
Phase 3CompletedGlaxoSmithKline3522005-07-112018-03-13
Once-Daily Investigational Nasal Spray In Adults And Adolescents With Vasomotor Rhinitis
GW685698X - Vasomotor Rhinitis, Rhinitis, Vasomotor
Phase 3CompletedGlaxoSmithKline3502005-07-012017-08-21
Efficacy of Esomeprazole for Non-Allergic Rhinitis: A Double-blind, Placebo Controlled Trial
esomeprazole, placebo - Vasomotor Rhinitis
Not applicableCompletedUniversity of Texas Southwestern Medical Center432005-06-012019-06-11
Impact of Acupuncture on Vasomotor Rhinitis
Acupuncture, Sham-laser acupuncture - Vasomotor Rhinitis, Acupuncture
Phase 3CompletedLudwig-Maximilians - University of Munich241998-01-012015-01-13

Narrower conditions

Common Cold (2)  ·  Rhinitis (2)  ·  Epistaxis (1)  ·  Laryngopharyngeal Reflux (1)  ·  Nasal Obstruction (1)  ·  Rhinitis, Allergic (1)  ·  Rhinitis, Allergic, Seasonal (1)  ·  Thyroid Nodule (1)

Broader conditions

Nose Diseases (12)  ·  Otorhinolaryngologic Diseases (12)  ·  Respiratory Tract Diseases (12)  ·  Rhinitis (10)  ·  Infections (3)  ·  Respiratory Tract Infections (3)  ·  Hypersensitivity (2)  ·  Hypersensitivity, Immediate (2)  ·  Immune System Diseases (2)  ·  Picornaviridae Infections (2)  ·  RNA Virus Infections (2)  ·  Respiratory Hypersensitivity (2)  ·  Virus Diseases (2)  ·  Airway Obstruction (1)  ·  Deglutition Disorders (1)

Interventions

levocetirizine (2)  ·  Acupuncture Therapy (1)  ·  Esomeprazole (1)  ·  Nasal Sprays (1)  ·  Olopatadine Hydrochloride (1)  ·  Oxymetazoline (1)  ·  Phenylephrine (1)  ·  Pseudoephedrine (1)  ·  Tablets (1)  ·  azelastine (1)

Sponsors

GlaxoSmithKline (2)  ·  Alcon Research (1)  ·  Associated Scientists to Help Minimize Allergies (1)  ·  Bayer (1)  ·  Camillians Saint Mary's Hospital Luodong (1)  ·  Cedars-Sinai Medical Center (1)  ·  Hanmi Pharmaceutical Company Limited (1)  ·  Liaquat University of Medical & Health Sciences (1)  ·  Lisa Shnayder (1)  ·  Ludwig-Maximilians - University of Munich (1)  ·  University of Texas Southwestern Medical Center (1)

Countries

United States (7)  ·  Germany (3)  ·  Canada (2)  ·  Czechia (2)  ·  Norway (2)  ·  Romania (2)  ·  Italy (1)  ·  Puerto Rico (1)  ·  South Korea (1)  ·  Taiwan (1)

Top investigators

Ankona Ghosh, MD (1)  ·  Cheng-Tsung Yang (1)  ·  David A Khan, MD (1)  ·  Dennis Shusterman, MD, MPH (1)  ·  Dominik Irnich, PD. Dr. (1)  ·  Kyungmi Park, Ph.D. (1)  ·  Stephen A Tilles,, MD (1)  ·  Yelizaveta Shnayder, MD (1)

Results publications

PMID 10606940, PMID 11707753, PMID 1197147, PMID 13766957, PMID 15339201, PMID 15878456, PMID 16490466, PMID 16719251, PMID 19281911, PMID 19388861, PMID 25629743, PMID 25644617, PMID 26760413, PMID 27115216, PMID 28602936, PMID 29438602, PMID 30215894, PMID 30239057, PMID 31179187, PMID 31690374, PMID 5926923, PMID 8120268, PMID 9031796, PMID 9500748